SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,549,000 | +60.1% | 450,000 | +51.3% | 2.20% | +84.6% |
| Q2 2023 | $34,069,700 | -40.6% | 297,500 | -28.5% | 1.19% | -37.5% |
| Q1 2023 | $57,337,280 | -58.1% | 416,000 | -60.6% | 1.90% | -35.8% |
| Q4 2022 | $136,706,900 | +30.4% | 1,055,000 | +11.3% | 2.96% | +39.0% |
| Q3 2022 | $104,814,000 | +182.8% | 948,200 | +336.2% | 2.13% | +77.1% |
| Q4 2020 | $37,065,000 | +373.6% | 217,400 | +171.8% | 1.20% | +11.2% |
| Q1 2020 | $7,826,000 | – | 80,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |